ORIGINAL RESEARCH
Accepted on 31 Mar 2025
Real-World Analysis of the Efficacy and Safety of Lorlatinib in ALK-Positive Non-Small Cell Lung Cancer Patients in China
doi 10.3389/fonc.2025.1577607
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Real-World Data and Real-World Evidence in Lung Cancer Volume II
Real-World Data and Real-World Evidence in Lung Cancer Volume II
364
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Oncology
Thoracic Oncology
Participating Journals
Frontiers in Public Health
- 3.0 impact factor
- 4.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: